Human whole blood for HbA1c research provides an erythrocyte-containing matrix for studying glycated hemoglobin (HbA1c), a form of hemoglobin generated by non-enzymatic glycation of hemoglobin in circulating red blood cells. HbA1c reflects glycemic exposure over approximately the preceding 2–3 months, with greater contribution from more recent glucose levels. Because HbA1c is influenced by both ambient glucose concentrations and erythrocyte turnover, whole blood is relevant for research investigating glucose metabolism, glycemic biomarkers, and factors affecting HbA1c interpretation.

Key Features

• Whole-Blood Matrix – Contains intact erythrocytes in which HbA1c is formed, supporting HbA1c measurement and analysis.

• Glycemic Biomarker – Enables investigation of longer-term glycemic exposure and relationships between HbA1c, glucose concentrations, and metabolic phenotypes.

• Analytical Research – Supports studies of HbA1c assay performance, standardization, analytical variability, and pre-analytical factors.

• Biological Variability – Suitable for investigating effects of erythrocyte lifespan, hematological conditions, and hemoglobin variants on HbA1c measurements.

Usual Research Uses

• Diabetes Research – Investigation of glycemic control and HbA1c as a biomarker of longer-term glycemic exposure.

• Metabolic Research – Analysis of relationships between HbA1c, glucose metabolism, and metabolic phenotypes.

• Epidemiological Studies – Investigation of HbA1c distributions and associations with metabolic and population-level characteristics.

• Biomarker Validation – Evaluation of HbA1c in studies of glycemic biomarkers and metabolic phenotypes.

• Glycemic-Control Research – Assessment of HbA1c in relation to longer-term glycemic exposure.

• HbA1c Assay Evaluation – Investigation of assay performance, analytical variability, standardization, and pre-analytical effects.

• Erythrocyte and Hemoglobin Research – Investigation of erythrocyte lifespan, hematological conditions, and hemoglobin variants that may affect HbA1c measurements.

• Pre-Analytical and Specimen-Stability Studies – Evaluation of how anticoagulant selection, storage conditions, and analytical methodology influence HbA1c measurement.